Page last updated: 2024-10-28

hexamethylene bisacetamide and Lymphoma, Large B-Cell, Diffuse

hexamethylene bisacetamide has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herwig, S1
Su, Q1
Zhang, W1
Ma, Y1
Tempst, P1
Xi, ZF1
Russell, M1
Woodward, S1
Thompson, F1
Wagner, L1
Taetle, R1

Other Studies

2 other studies available for hexamethylene bisacetamide and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Acetamides; Biomarkers; Blood Proteins; Cell Differentiation; Cycloheximide; Cytokines; Dactinomycin

1996
Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Leukemia, 1997, Volume: 11, Issue:2

    Topics: Acetamides; Alitretinoin; Cell Differentiation; DNA-Binding Proteins; Gene Expression Regulation, Le

1997